New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Johnson & Johnson to Acquire Synthes

According to GlobalData, Johnson & Johnson (J&J) has agreed to acquire Synthes Inc. for about $21.3 billion in cash and stock.

The deal would help J&J to further diversify, making it the global leader in the trauma fixation devices market which according to GlobalData estimates was valued at $4.6 billion in 2010. Synthes is the global leader in this market and held more than 40% share in 2009.

Synthes also holds a leadership position in the cranio maxillofacial fixation (CMF) market with a share of 34.6% in 2009. Besides this, it's the third largest player globally in the spinal surgery devices market with an estimated share of 11.7% in 2009. The global CMF and spinal surgery devices markets were valued at $652m and $7 billion respectively in 2010.

In 2010, J&J had to recall more than 50 drugs and devices which cost the company $900m in sales. J&J's McNeil consumer healthcare unit and the hip replacement implants business were the primary businesses impacted by the product recalls. J&J removed almost 200 million packages of Tylenol, Motrin and other over-the-counter (OTC) medications within its McNeil consumer healthcare business and recalled about 93,000 hip implants in its DePuy franchise.

Essentially, at a time when J&J has been hit by product recalls and changing market dynamics, this acquisition would not only help the company expand its offerings but also in exploring synergies and cross-selling opportunities.
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts